Intra-Cellular Therapies
ITCI
#1264
Rank
C$19.48 B
Marketcap
$182.92
Share price
0.00%
Change (1 day)
80.93%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.17

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.23. In 2022 the company made an earnings per share (EPS) of -$3.77 an increase over its 2021 EPS that were of -$4.86.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.17-42.52%
2022-$3.77-22.29%
2021-$4.868.02%
2020-$4.4920.9%
2019-$3.72-5.63%
2018-$3.9433.96%
2017-$2.94-21.19%
2016-$3.73-7.56%
2015-$4.04174.53%
2014-$1.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.35-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.87 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.97 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA